Cardiac Imaging

What Is the Best Imaging Study for Post-Fontan Evaluation After an Inadequate Echocardiogram?

·
What Is the Best Imaging Study for Post-Fontan Evaluation After an Inadequate Echocardiogram?

A 24-year-old with a history of tricuspid atresia, now status-post a total cavopulmonary connection (Fontan procedure), presents for their annual cardiology follow-up. They feel well, but their routine transthoracic echocardiogram is limited by poor acoustic windows, leaving the Fontan pathway, pulmonary arteries, and systemic ventricular function inadequately visualized. The clinical question is clear: what is the most effective and safest way to get a comprehensive look at their complex circulation? This article details the clinical workflow for this specific scenario, where the American College of Radiology (ACR) has determined that MRA chest without and with IV contrast is a Usually Appropriate next step.

Who Fits This Clinical Scenario for Post-Fontan Evaluation?

This guidance applies to a specific patient population: children or adults with single ventricle physiology who have completed the final stage of surgical palliation, the Fontan procedure or total cavopulmonary connection (TCPC). The critical trigger for this workflow is an incomplete or technically inadequate transthoracic echocardiogram (TTE) that fails to provide a definitive assessment of cardiovascular anatomy and function.

This workflow is distinct from several related clinical situations:

  • Preoperative Evaluation: This guidance does not apply to patients being evaluated before their stage 2 (Glenn) or stage 3 (Fontan) palliation. Those preoperative scenarios have their own dedicated ACR Appropriateness Criteria variants that focus on defining anatomy for surgical planning.
  • Different Congenital Lesions: This workflow is specific to the post-Fontan single ventricle population. Patients with other complex congenital heart diseases, such as repaired tetralogy of Fallot or transposition of the great arteries, have unique long-term complications and follow different imaging pathways.
  • Adequate Echocardiography: If a TTE provides a complete and clear assessment of the Fontan circuit and ventricular function, advanced imaging may not be immediately necessary for routine surveillance, and a “watchful waiting” approach may be appropriate. This workflow is reserved for when the primary non-invasive tool is insufficient.

What Complications Are You Assessing in a Post-Fontan Patient?

In a patient with Fontan circulation, imaging is not about finding a new diagnosis but about surveillance for known, progressive complications of this unique non-physiologic circulatory state. The goal is to identify problems before they become clinically catastrophic.

The primary concerns being evaluated include Fontan pathway obstruction or thrombosis. The surgically created conduit or baffle is susceptible to stenosis, kinking, or thrombus formation. Any obstruction dramatically increases systemic venous pressure, which can lead to hepatic congestion, protein-losing enteropathy, plastic bronchitis, and ultimate circulatory failure. This is often the most urgent finding to rule out.

Another key objective is assessing systemic ventricular dysfunction. The single ventricle is subjected to a lifetime of abnormal loading conditions, predisposing it to progressive dilation, hypertrophy, and failure. Accurate measurement of ventricular volume and ejection fraction is paramount for prognosis and timing of advanced heart failure therapies.

Clinicians are also searching for the development of systemic-to-pulmonary or veno-venous collateral vessels. These abnormal connections can form over time, leading to arterial desaturation (cyanosis) and an inefficient circulatory pathway where deoxygenated blood bypasses the lungs. Identifying and quantifying the flow through these collaterals is essential.

Finally, imaging can reveal the downstream consequences of elevated central venous pressure, such as hepatic congestion, which can progress to Fontan-associated liver disease (FALD). While not diagnostic for FALD, imaging can provide supportive evidence of the underlying hemodynamic strain.

Why Is MRA Chest the Recommended Next Step After an Inadequate Echocardiogram?

For a comprehensive, non-invasive evaluation of the post-Fontan patient with an inconclusive echocardiogram, Magnetic Resonance Angiography (MRA) of the chest, typically performed as part of a broader Cardiovascular Magnetic Resonance (CMR) study, is designated as Usually Appropriate by the ACR.

The primary strength of MRI/MRA is its ability to provide a complete anatomical and functional assessment in a single, radiation-free examination.

  • Superior Anatomical Detail: MRA creates a detailed three-dimensional map of the entire thoracic circulation, including the full Fontan pathway (baffle or extracardiac conduit), superior and inferior vena cavae, and the central and branch pulmonary arteries. It is highly sensitive for detecting stenosis, thrombosis, or external compression that may be missed by echocardiography due to acoustic window limitations.
  • Gold-Standard Functional Assessment: CMR sequences are the reference standard for quantifying ventricular volumes, mass, and ejection fraction. This is especially true in single ventricles, which are often morphologically complex and non-elliptical, making the geometric assumptions of 2D echocardiography unreliable.
  • No Ionizing Radiation: Patients with single ventricle physiology require lifelong imaging surveillance. Choosing a radiation-free modality (adult_rrl=O 0 mSv, ped_rrl=O 0 mSv [ped]) is critical to minimize cumulative radiation exposure over a patient’s lifetime.
  • Flow Quantification and Tissue Characterization: Advanced CMR techniques can directly measure blood flow, calculate shunt fractions from collateral vessels, and assess for myocardial fibrosis using late gadolinium enhancement (LGE), which is a powerful prognostic marker.

How do other modalities compare for this specific scenario?

  • CTA chest with IV contrast is also rated Usually Appropriate. It provides excellent, rapid anatomical detail of the Fontan circuit. However, it delivers a significant radiation dose (ped_rrl=☢☢☢☢ 3-10 mSv [ped]) and offers substantially less functional information about the ventricle compared to MRI. It remains an excellent alternative when MRI is contraindicated (e.g., incompatible implanted device) or unavailable.
  • Transesophageal echocardiography (TEE) is rated May be appropriate. While it overcomes the body habitus limitations of TTE, it is an invasive procedure requiring sedation or general anesthesia. Furthermore, it may still have blind spots, particularly for more distal pulmonary artery branches or extracardiac portions of the Fontan circuit.

What Is the Downstream Workflow After a Post-Fontan Cardiac MRI/MRA?

The results of the MRI/MRA directly guide the next steps in management, which are often multidisciplinary and involve cardiology, interventional cardiology, and surgery.

  • If the study reveals significant Fontan pathway obstruction or thrombosis: This is an urgent finding. The patient should be referred for cardiac catheterization to confirm hemodynamics and plan for intervention, such as balloon angioplasty or stent placement. Anticoagulation therapy will also be reviewed and optimized.
  • If the study shows progressive systemic ventricular dysfunction: This finding triggers an intensification of medical therapy for heart failure. It may also prompt discussions about the need for advanced therapies, such as evaluation for a ventricular assist device (VAD) or heart transplantation.
  • If the study identifies large, hemodynamically significant collateral vessels: The patient may be referred for catheter-based intervention to close the collaterals (e.g., coil embolization). This can improve systemic oxygen saturation and make the Fontan circulation more efficient.
  • If the study is negative or shows stable, non-progressive findings: The MRI/MRA provides a new, comprehensive baseline. The patient can typically return to routine clinical and echocardiographic surveillance, with the next advanced imaging study timed based on clinical status and institutional protocols.
  • If the study is indeterminate: In rare cases, artifact (e.g., from a previous stent) may limit evaluation. This may lead to a discussion with the patient about the risks and benefits of proceeding with a diagnostic cardiac catheterization, an invasive procedure rated May be appropriate.

Pitfalls to Avoid (and When to Get Help)

Navigating the imaging workup for post-Fontan patients requires careful planning to ensure a diagnostic-quality study that safely answers the clinical questions.

  • Failing to Plan for Sedation/Anesthesia: MRI scans are long, and motion can degrade image quality. For pediatric patients or anxious adults, a low threshold for planned sedation or general anesthesia is crucial to obtaining a diagnostic study.
  • Overlooking Device Compatibility: Before ordering an MRI, rigorously screen for any implanted cardiac devices (pacemakers, defibrillators, abandoned leads) and confirm their MRI safety status according to institutional protocols.
  • Vague Imaging Requisitions: A generic order like “CMR” is insufficient. Clearly communicate the specific clinical questions to the radiology team (e.g., “Evaluate for Fontan baffle stenosis,” “Quantify aortopulmonary collateral flow,” “Assess for ventricular fibrosis”). This ensures the protocol is tailored correctly.
  • Ignoring Renal Function: Always check the patient’s estimated glomerular filtration rate (eGFR) before administering a gadolinium-based contrast agent, especially in this population at risk for cardiorenal syndrome.

If significant hemodynamic compromise is suspected clinically, or if the MRI reveals a critical finding like a large pathway thrombus, immediate consultation with an adult congenital heart disease (ACHD) specialist or congenital cardiac interventionalist is warranted.

Related ACR Topics and Tools

This article covers one specific workflow within the broader topic of congenital and acquired heart disease. For additional resources and related scenarios, please refer to the following:

Frequently Asked Questions

Why is MRA preferred over CTA if both are ‘Usually Appropriate’ for post-Fontan evaluation?

While both provide excellent anatomical detail, MRA/CMR is generally preferred because it involves no ionizing radiation, which is a key consideration for patients requiring lifelong surveillance. Additionally, CMR provides superior functional data, including gold-standard ventricular volume and function assessment, flow quantification, and tissue characterization for fibrosis, which are not available with CTA.

Is contrast always necessary for a post-Fontan MRI study?

While a non-contrast study can provide some functional and anatomical information, a gadolinium-based contrast agent is crucial for a complete evaluation. Contrast is essential for the MRA portion to clearly delineate the vascular anatomy of the Fontan circuit and for late gadolinium enhancement (LGE) sequences to assess for myocardial fibrosis, a key prognostic marker. The ACR lists both ‘MRA chest without and with IV contrast’ and ‘MRI heart function and morphology without and with IV contrast’ as ‘Usually Appropriate’.

What if my patient has a pacemaker or ICD that is not MRI-conditional?

If a patient has an implanted cardiac device that is not compatible with MRI, CTA chest with IV contrast becomes the best alternative. It is also rated ‘Usually Appropriate’ by the ACR and will provide excellent anatomical assessment of the Fontan pathway, though with less functional information and with the tradeoff of radiation exposure.

Can cardiac catheterization be used instead of MRI or CT?

Cardiac catheterization is an invasive procedure and is rated ‘May be appropriate’ for this initial evaluation after an inadequate echo. It is typically reserved for cases where non-invasive imaging (MRI or CT) is indeterminate or reveals a significant abnormality that requires direct pressure measurements or intervention, such as stenting a stenotic pathway.

How often should a post-Fontan patient receive an MRI or CTA?

The frequency of advanced imaging is not standardized and depends on the patient’s clinical stability, findings on previous studies, and institutional protocols. Many centers perform a baseline MRI/MRA a few years after the Fontan operation and then repeat it every 3-5 years or sooner if there is a change in clinical status, new symptoms, or concerning findings on their annual echocardiogram.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026